⌘K

Home/Filings/4/0000950170-25-086141

4//SEC Filing

Baynes Roy D. 4

Accession 0000950170-25-086141

CIK 0001774857other

View on SEC.gov Company Profile

Filed

Jun 12, 8:00 PM ET

Accepted

Jun 13, 4:05 PM ET

Size

5.2 KB

Accession

0000950170-25-086141

Insider Transaction Report

Form 4

Period: 2025-06-11

Aardvark Therapeutics, Inc.AARD

Director

Transactions

Award
Stock Option (right to buy)
2025-06-11+30,508→ 30,508 total
Exercise: $11.29Exp: 2035-06-11→ Common Stock (30,508 underlying)

Footnotes (1)

[F1]The option shall vest in full on June 11, 2026, subject to the Reporting Person's continuous service through the vesting date, inclusive.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Aardvark Therapeutics, Inc.

CIK 0001774857

Entity typeother

Related Parties

1

filerCIK 0001680739

Filing Metadata

Form type: 4
Filed: Jun 12, 8:00 PM ET
Accepted: Jun 13, 4:05 PM ET
Size: 5.2 KB

View on SEC.gov